July 24, 2008
| Bio-IT World > Champions 2.0
Champions 2.0


March 12, 2007

Abrevity
Joel Harrison
CTO

How has your company adapted and responded to the changing economic climate in the past five years when so many others companies did not?

Abrevity was founded in 2003 and self funded until 2005. We knew when we built the company that initially getting outside funding would be difficult because of the economic climate at that time but knew that our core technology and value proposition could not wait until the climate changed. In 2005 we took our first product to market and it was successful which allowed us to quickly grow the company.

What is your vision for the future of the life sciences market over the next several years?

One of the biggest IT pains in the life sciences market today is managing the issue of exponential data growth. Abrevity will continue to advance our products in the data management aspect of life sciences. We see our products becoming the leading product in managing large amounts of clinical research, pharma, and life science experiment data.

What products and services does your company provide and what special capabilities do they offer the life sciences market?

Abrevity’s FileData Classifier and FileData Manager products with the addition of our Bio Extraction module allows data being created by bio-instruments such as Flow Cytometers and Microscopes to the indexed, search, classified (tagged), and managed.  Our unique technology allows users to manage the files associated with experiments as a single object or “classification bucket”. This allows pertinent data to be mined out of the files while keeping a full index of the other data for future use.

Partnerships are an effective way to track life science advances and ensure that your company delivers timely products and services. Which life sciences companies or organizations have you partnered with or invested in and why?

We have worked closely with instrument manufacturers and research firms such as BD Biosciences because we have expertise in data management and they have the expertise in the life sciences instruments.

What are your most exciting products and initiatives in development, and how will they improve life science research?

We are excited about the fact that our products allow Scientists, Researchers, and Bio-IT professionals to spend more time doing their core job, and not spending time manually managing data.  We think that we can help speed up research by removing the daunting tasks of administration, data mining, report generation, and audit compliance.

Where do you see your company in five years?

In five years, we will be the leading application and data management framework vendor to manage all types of unstructured, semi-structured, and structured data.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

definiens briefingon-76Next-Generation Technologies Revolutionizing Oncology and Diagnostics
underwritten by Definiens

This “Briefing On” collection of Bio-IT World features, commentaries and analysis, presents some of the latest thinking on high-throughput technologies that are being applied to the fields of research and drug discovery, with particular emphasis on oncology, diagnostics and imaging technologies. Download now at no charge compliments of the underwriting sponsor, Definiens. Download This Free Paper



gq nxt gen seq

This Bio•IT World Briefing On “Next-Generation Sequencing,” underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data.  Download now 



metaminerMetaMiner™ Cystic Fibrosis Report
Sponsored by GeneGo

This paper discusses the MetaMiner™ (CF) data analysis platform for a broad range of CF researchers designed to:

1. Easily assemble important biological and chemical experimental data available today in cystic fibrosis research.
2. Visualize key mechanisms leading to the disease through pathway maps and network models.
3. Provide the CF community a “one stop shop” tool for uploading and analyzing experimental data in a disease-centered interface.
Download Now

 



Life Science Webcasts & Podcasts

GenoLogicsgenologics 2 translational
Enabling Translational Research Informatics

Learn about the challenges facing life sciences research labs to manage their translational research data:

  • The trends for organizations to adopt informatics solutions for translational research.
  • The unique requirements with managing complex data and workflow.
  • What labs should consider when reviewing informatics solutions for translational research.
  • Which life sciences research organizations are successfully adopting an informatics solution.

Download Now



More Podcasts

Job Openings

Assistant Editor (Science Writer)~Cambridge Healthtech Institute (CHI), Needham, MA, 
Cambridge Healthtech Institute seeks an assistant editor (science writer) who is an ambitious, dependable journalist who can fulfill a range of writing and editorial duties for a series of eNewsletters covering various aspects of the biopharmaceutical industry in addition to CHI’s flagship publication, Bio-IT World magazine.  This is a superb opportunity to make important contributions to the growth and success of a multimedia science publishing group, while gaining invaluable experience in multiple facets of the publishing industry.   Interested candidates should submit a cover letter, including 3 writing samples (attached in Word or PDF format), salary history or requirements, and resume to kdavies@healthtech.com. For a detailed description of the Assistant Editor position, please click here.

Fred Hutchinson Cancer Research Center: IT Business Analyst III
The Hutchinson Center is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Through our Tumor Research Initiative, we are finding new ways to detect tumors at an early stage.  We are presently seeking an experienced IT Business Analyst to assess technology needs for the Tumor Research Initiative, and to identify and design improvements to computer based systems.  For more information please visit www.fhcrc.org and search for Job# AD-21465





For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext 100 or via email to bio-itworld@theygsgroup.com.